In vivo and in vitro experiments also demonstrated that targeted demethylation of the SLC5A7 promoter can strongly inhibit tumor proliferation and progression, and these effects might be mediated by increased SLC5A7 expression. The gene discussed is SLC5A7; the disease is neoplasm.